NOX4 and diabetic kidney disease: This is especially relevant in the context of human DKD, where both NOX4 and NOX5 are endogenously expressed and, as per these findings, inhibiting NOX4 would not sufficiently attenuate albuminuria in the presence of NOX5 expression.